“... Of as high a quality as we had supplied before the European War. Thanks to the research and scientific achievement of Our Chemists, we are now able to offer LIQUID ALBOLENE, using as a base a specially refined Domestic Oil that is in every way suitable for medicinal purposes, and having the same viscosity as Russian Oil.” The advertising matter suggests the promiscuous, thoughtless and irrational use of Liquid Albolene and of a number of Albolene preparations by extravagant claims, such, for example, as the following: “Albolene will never fail to bring a free, easy stool, no matter what condition may be present, from obstinate atony of the bowel to fissure, fistula, or even malignant disease, and in spite of the failure of ordinary purgatives to which the patient may have become habituated.... “Aromatic Liquid Albolene is actually the first laxative presented to the medical profession that seems to have no drawback.... “It will not have been lost upon the physician who has read the remarks on the use of Aromatic Liquid Albolene to regulate the bowels in surgical cases, that there are many instances where it would prove equally valuable during the treatment of acute diseases. In the exanthemata, in pneumonia, for example, to cite only a few of the conditions where it may be used to advantage, an absolutely reliable laxative that will not in any way weaken or distress the patient, presents obvious superiority to any of the agents heretofore in common use.” The Council held Liquid Albolene ineligible because the product is marketed in a way to encourage its indiscriminate and irrational use by the public (Rule 4) and because unwarranted therapeutic claims are made for it (Rule 6).--(_From Reports of Council on Pharmacy and Chemistry, 1916, p. 65._) NAPHEY’S MEDICATED UTERINE WAFERS Report of the Council on Pharmacy and Chemistry Naphey’s Medicated Uterine Wafers were submitted to the Council by the manufacturers, Naphey & Co., some years ago and were rejected. Naphey & Co. has recently requested reconsideration of the preparation, and has submitted advertising matter, trade packages and sample packages. The label of the trade package contains the following: “Naphey’s Wafers. For the local treatment of diseases of women, indicated in catarrhal conditions of the vagina, and of the uterine cervix. As a [_sic!_] adjuvant for the physician to use in carrying out treatment of disease of the uterus.” “Zinc Sulphate, 3-3/4 gr., Sodium Sulphate, 3-1/2 gr., Sodium Borate, 4 gr., Boric Acid, 3/4 gr.” “Naphey & Co., Warren, Pa., U. S. A.” “Each box contains 25 wafers, sufficient for three months’ treatment. Price per box, 25c.”